Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS

British Journal of Pharmacology

Volumn 171, Issue 6, 2014, Pages 1379-1391

  Murataeva, N ^a   Straiker, A ^a   MacKie, K ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

2 AG; arachidonic acid; cannabinoid; diacylglycerol; hydrolysis; metabolism; monoacylglycerol lipase; synaptic plasticity; synthesis

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; CYCLOOXYGENASE 2; DIACYLGLYCEROL LIPASE ALPHA; DIACYLGLYCEROL LIPASE BETA; ESTER DERIVATIVE; FATTY ACID AMIDASE; LIPOPROTEIN LIPASE; MESSENGER RNA; PROSTAGLANDIN GLYCEROL ESTER; UNCLASSIFIED DRUG;

ACYLATION; CELLULAR DISTRIBUTION; CENTRAL NERVOUS SYSTEM; ENZYME ACTIVITY; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME STRUCTURE; GENE INACTIVATION; GOLGI COMPLEX; HUMAN; LIPID DEGRADATION; LIPOGENESIS; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NEUROMODULATION; NONHUMAN; OXYGENATION; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC NERVE; PRESYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY;

2-AG; ARACHIDONIC ACID; CANNABINOID; DIACYLGLYCEROL; HYDROLYSIS; METABOLISM; MONOACYLGLYCEROL LIPASE; SYNAPTIC PLASTICITY; SYNTHESIS;

ACYLATION; ANIMALS; ARACHIDONIC ACIDS; CENTRAL NERVOUS SYSTEM; ENDOCANNABINOIDS; GLYCERIDES; HUMANS; MONOACYLGLYCEROL LIPASES; PHOSPHORYLATION;

EID: 84895765600     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12411     Document Type: Review

References (113)

1. Ahn K, McKinney MK, Cravatt BF, (2008). Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 108: 1687-1707. (Pubitemid 351796405)
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol 170: 1449-1867.
3. Alger BE, Kim J, (2011). Supply and demand for endocannabinoids. Trends Neurosci 34: 304-315.
4. 2 cannabinoid receptors inhibit synaptic transmission when expressed in cultured autaptic neurons. Neuropharmacology 63: 514-523.
5. Bauer M, Chicca A, Tamborrini M, Eisen D, Lerner R, Lutz B, et al. (2012). Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors. J Biol Chem 287: 36944-36967.
6. Bektas M, Payne SG, Liu H, Goparaju S, Milstien S, Spiegel S, (2005). A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cells. J Cell Biol 169: 801-811. (Pubitemid 41002885)
7. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, et al. (2003). Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163: 463-468. (Pubitemid 37429860)
8. Blankman JL, Simon GM, Cravatt BF, (2007). A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14: 1347-1356. (Pubitemid 350257008)
9. Blankman JL, Long JZ, Trauger SA, Siuzdak G, Cravatt BF, (2013). ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC. Proc Natl Acad Sci U S A 110: 1500-1505.
10. Bowman AL, Makriyannis A, (2013). Highly predictive ligand-based pharmacophore and homology models of ABHD6. Chem Biol Drug Des 81: 382-388.
11. Brenowitz SD, Regehr WG, (2005). Associative short-term synaptic plasticity mediated by endocannabinoids. Neuron 45: 419-431. (Pubitemid 40188209)
12. Busquets-Garcia A, Puighermanal E, Pastor A, de la Torre R, Maldonado R, Ozaita A, (2011). Differential role of anandamide and 2-arachidonoylglycerol in memory and anxiety-like responses. Biol Psychiatry 70: 479-486.
13. Caille S, Alvarez-Jaimes L, Polis I, Stouffer DG, Parsons LH, (2007). Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J Neurosci 27: 3695-3702. (Pubitemid 46557675)
14. Cao J, Lockwood J, Burn P, Shi Y, (2003). Cloning and functional characterization of a mouse intestinal acyl-CoA:monoacylglycerol acyltransferase, MGAT2. J Biol Chem 278: 13860-13866. (Pubitemid 36799925)
15. Chanda PK, Gao Y, Mark L, Btesh J, Strassle BW, Lu P, et al. (2010). Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol Pharmacol 78: 996-1003.
16. Chen JK, Chen J, Imig JD, Wei S, Hachey DL, Guthi JS, et al. (2008). Identification of novel endogenous cytochrome p450 arachidonate metabolites with high affinity for cannabinoid receptors. J Biol Chem 283: 24514-24524.
17. Chevaleyre V, Castillo PE, (2003). Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38: 461-472. (Pubitemid 36579147)
18. Choi JW, Herr DR, Noguchi K, Yung YC, Lee CW, Mutoh T, et al. (2010). LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol 50: 157-186.
19. Coleman RA, Haynes EB, (1986). Monoacylglycerol acyltransferase. Evidence that the activities from rat intestine and suckling liver are tissue-specific isoenzymes. J Biol Chem 261: 224-228. (Pubitemid 16102871)
20. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB, (1996). Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 384: 83-87. (Pubitemid 26374593)
21. Cravatt BF, Demarest K, Patricelli MP, Bracey MH, Giang DK, Martin BR, et al. (2001). Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc Natl Acad Sci U S A 98: 9371-9376. (Pubitemid 32743923)
22. Devane WA, Dysarz FA, 3rd, Johnson MR, Melvin LS, Howlett AC, (1988). Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 34: 605-613. (Pubitemid 19007296)
23. Di Marzo V, Melck D, Bisogno T, De Petrocellis L, (1998). Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21: 521-528. (Pubitemid 28555694)
24. Duggan KC, Hermanson DJ, Musee J, Prusakiewicz JJ, Scheib JL, Carter BD, et al. (2011) (R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2. Nat Chem Biol 7: 803-809.
25. Egertova M, Cravatt BF, Elphick MR, (2003). Comparative analysis of fatty acid amide hydrolase and CB1 cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 119: 481-496. (Pubitemid 36588826)
26. Farooqui AA, Rammohan KW, Horrocks LA, (1989). Isolation, characterization, and regulation of diacylglycerol lipases from the bovine brain. Ann N Y Acad Sci 559: 25-36. (Pubitemid 19215825)
27. Fiskerstrand T, H'Mida-Ben Brahim D, Johansson S, M'Zahem A, Haukanes BI, Drouot N, et al. (2010). Mutations in ABHD12 cause the neurodegenerative disease PHARC: an inborn error of endocannabinoid metabolism. Am J Hum Genet 87: 410-417.
28. Freund TF, Katona I, Piomelli D, (2003). Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83: 1017-1066. (Pubitemid 36828930)
29. Galiegue S, Mary S, Marchand J, Dussossoy D, Carriere D, Carayon P, et al. (1995). Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 232: 54-61.
30. Gao Y, Vasilyev DV, Goncalves MB, Howell FV, Hobbs C, Reisenberg M, et al. (2010). Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 30: 2017-2024.
31. Ghosh S, Wise LE, Chen Y, Gujjar R, Mahadevan A, Cravatt BF, et al. (2013). The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model. Life Sci 92: 498-505.
32. Goparaju SK, Ueda N, Yamaguchi H, Yamamoto S, (1998). Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand. FEBS Lett 422: 69-73. (Pubitemid 28052868)
33. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F, et al. (2004). Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20: 441-458. (Pubitemid 38969629)
34. Hashimotodani Y, Ohno-Shosaku T, Tanimura A, Kita Y, Sano Y, Shimizu T, et al. (2013). Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde synaptic suppression: evidence for on-demand biosynthesis of 2-arachidonoylglycerol. J Physiol 591: 4765-4776.
35. Heimann AS, Gomes I, Dale CS, Pagano RL, Gupta A, de Souza LL, et al. (2007). Hemopressin is an inverse agonist of CB1 cannabinoid receptors. Proc Natl Acad Sci U S A 104: 20588-20593.
36. Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR, et al. (1990). Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87: 1932-1936.
37. Hermanson DJ, Hartley ND, Gamble-George J, Brown N, Shonesy BC, Kingsley PJ, et al. (2013). Substrate-selective COX-2 inhibition decreases anxiety via endocannabinoid activation. Nat Neurosci 16: 1291-1298.
38. Higgs HN, Glomset JA, (1994). Identification of a phosphatidic acid-preferring phospholipase A1 from bovine brain and testis. Proc Natl Acad Sci U S A 91: 9574-9578. (Pubitemid 24297957)
39. Ho WS, Randall MD, (2007). Endothelium-dependent metabolism by endocannabinoid hydrolases and cyclooxygenases limits vasorelaxation to anandamide and 2-arachidonoylglycerol. Br J Pharmacol 150: 641-651. (Pubitemid 46355564)
40. Hohmann AG, Martin WJ, Tsou K, Walker JM, (1995). Inhibition of noxious stimulus-evoked activity of spinal cord dorsal horn neurons by the cannabinoid WIN 55,212-2. Life Sci 56: 2111-2118.
41. Hsu KL, Tsuboi K, Adibekian A, Pugh H, Masuda K, Cravatt BF, (2012). DAGLbeta inhibition perturbs a lipid network involved in macrophage inflammatory responses. Nat Chem Biol 8: 999-1007.
42. Hu SS, Bradshaw HB, Chen JS, Tan B, Walker JM, (2008). Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity. Br J Pharmacol 153: 1538-1549. (Pubitemid 351481525)
43. Hu SS, Arnold A, Hutchens JM, Radicke J, Cravatt BF, Wager-Miller J, et al. (2010). Architecture of cannabinoid signaling in mouse retina. J Comp Neurol 518: 3848-3866.
44. Jaeger KE, Dijkstra BW, Reetz MT, (1999). Bacterial biocatalysts: molecular biology, three-dimensional structures, and biotechnological applications of lipases. Annu Rev Microbiol 53: 315-351. (Pubitemid 29503734)
45. Jain T, Wager-Miller J, Mackie K, Straiker A, (2013). DAGLα and DAGLβ cooperatively regulate the production of 2-arachidonoyl glycerol in autaptic hippocampal neurons. Mol Pharmacol 84: 296-302.
46. Jeong WI, Osei-Hyiaman D, Park O, Liu J, Batkai S, Mukhopadhyay P, et al. (2008). Paracrine activation of hepatic CB1 receptors by stellate cell-derived endocannabinoids mediates alcoholic fatty liver. Cell Metab 7: 227-235. (Pubitemid 351285525)
47. Jung KM, Astarita G, Zhu C, Wallace M, Mackie K, Piomelli D, (2007). A key role for diacylglycerol lipase-alpha in metabotropic glutamate receptor-dependent endocannabinoid mobilization. Mol Pharmacol 72: 612-621. (Pubitemid 47347296)
48. Kano M, Ohno-Shosaku T, Maejima T, (2002). Retrograde signaling at central synapses via endogenous cannabinoids. Mol Psychiatry 7: 234-235. (Pubitemid 34280630)
49. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M, Watanabe M, (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89: 309-380.
50. Kanoh H, Iwata T, Ono T, Suzuki T, (1986). Immunological characterization of sn-1,2-diacylglycerol and sn-2-monoacylglycerol kinase from pig brain. J Biol Chem 261: 5597-5602. (Pubitemid 17204378)
51. Karlsson M, Contreras JA, Hellman U, Tornqvist H, Holm C, (1997). cDNA cloning, tissue distribution, and identification of the catalytic triad of monoglyceride lipase. Evolutionary relationship to esterases, lysophospholipases, and haloperoxidases. J Biol Chem 272: 27218-27223. (Pubitemid 27452682)
52. Karlsson M, Reue K, Xia YR, Lusis AJ, Langin D, Tornqvist H, et al. (2001). Exon-intron organization and chromosomal localization of the mouse monoglyceride lipase gene. Gene 272: 11-18. (Pubitemid 32695393)
53. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, et al. (2003). Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76-81. (Pubitemid 36098263)
54. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, et al. (2006). Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26: 5628-5637. (Pubitemid 44315254)
55. Keimpema E, Barabas K, Morozov YM, Tortoriello G, Torii M, Cameron G, et al. (2010). Differential subcellular recruitment of monoacylglycerol lipase generates spatial specificity of 2-arachidonoyl glycerol signaling during axonal pathfinding. J Neurosci 30: 13992-14007.
56. Keimpema E, Mackie K, Harkany T, (2011). Molecular model of cannabis sensitivity in developing neuronal circuits. Trends Pharmacol Sci 32: 551-561.
57. Kim J, Alger BE, (2004). Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus. Nat Neurosci 7: 697-698. (Pubitemid 38859050)
58. King AR, Lodola A, Carmi C, Fu J, Mor M, Piomelli D, (2009). A critical cysteine residue in monoacylglycerol lipase is targeted by a new class of isothiazolinone-based enzyme inhibitors. Br J Pharmacol 157: 974-983.
59. Kinsey SG, Nomura DK, O'Neal ST, Long JZ, Mahadevan A, Cravatt BF, et al. (2011). Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice. J Pharmacol Exp Ther 338: 795-802.
60. Kishimoto Y, Kano M, (2006). Endogenous cannabinoid signaling through the CB1 receptor is essential for cerebellum-dependent discrete motor learning. J Neurosci 26: 8829-8837. (Pubitemid 44319418)
61. Kozak KR, Marnett LJ, (2002). Oxidative metabolism of endocannabinoids. Prostaglandins Leukot Essent Fatty Acids 66: 211-220. (Pubitemid 34743596)
62. Kozak KR, Rowlinson SW, Marnett LJ, (2000). Oxygenation of the endocannabinoid, 2-arachidonylglycerol, to glyceryl prostaglandins by cyclooxygenase-2. J Biol Chem 275: 33744-33749.
63. Lapchak PA, Araujo DM, Song D, Zivin JA, (2001). Neuroprotection by the selective cyclooxygenase-2 inhibitor SC-236 results in improvements in behavioral deficits induced by reversible spinal cord ischemia. Stroke 32: 1220-1225. (Pubitemid 32825814)
64. Li F, Fei X, Xu J, Ji C, (2009). An unannotated alpha/beta hydrolase superfamily member, ABHD6 differentially expressed among cancer cell lines. Mol Biol Rep 36: 691-696.
65. Lichtman AH, Hawkins EG, Griffin G, Cravatt BF, (2002). Pharmacological activity of fatty acid amides is regulated, but not mediated, by fatty acid amide hydrolase in vivo. J Pharmacol Exp Ther 302: 73-79. (Pubitemid 34680423)
66. Long JZ, Li W, Booker L, Burston JJ, Kinsey SG, Schlosburg JE, et al. (2009). Selective blockade of 2-arachidonoylglycerol hydrolysis produces cannabinoid behavioral effects. Nat Chem Bio 5: 37-44.
67. Ludanyi A, Hu SS, Yamazaki M, Tanimura A, Piomelli D, Watanabe M, et al. (2011). Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience 174: 50-63.
68. Maccarrone M, Salvati S, Bari M, Finazzi A, (2000). Anandamide and 2-arachidonoylglycerol inhibit fatty acid amide hydrolase by activating the lipoxygenase pathway of the arachidonate cascade. Biochem Biophys Res Commun 278: 576-583.
69. Marrs WR, Blankman JL, Horne EA, Thomazeau A, Lin YH, Coy J, et al. (2010). The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. Nat Neurosci 13: 951-957.
70. Marrs WR, Horne EA, Ortega-Gutierrez S, Cisneros JA, Xu C, Lin YH, et al. (2011). Dual inhibition of alpha/beta-hydrolase domain 6 and fatty acid amide hydrolase increases endocannabinoid levels in neurons. J Biol Chem 286: 28723-28728.
71. Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, et al. (1994). Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc Natl Acad Sci U S A 91: 3228-3232. (Pubitemid 24130209)
72. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI, (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
73. Mechoulam R, Gaoni Y, (1965). A total synthesis of Dl-Delta-1- Tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87: 3273-3275.
74. Moody JS, Kozak KR, Ji C, Marnett LJ, (2001). Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. Biochemistry 40: 861-866. (Pubitemid 32108577)
75. Moolenaar WH, Kranenburg O, Postma FR, Zondag GC, (1997). Lysophosphatidic acid: G-protein signalling and cellular responses. Curr Opin Cell Biol 9: 168-173. (Pubitemid 27135983)
76. Muccioli GG, Xu C, Odah E, Cudaback E, Cisneros JA, Lambert DM, et al. (2007). Identification of a novel endocannabinoid-hydrolyzing enzyme expressed by microglial cells. J Neurosci 27: 2883-2889. (Pubitemid 46438968)
77. Mukhopadhyay S, Howlett AC, (2001). CB1 receptor-G protein association. Subtype selectivity is determined by distinct intracellular domains. Eur J Biochem 268: 499-505. (Pubitemid 32862606)
78. Mulder J, Aguado T, Keimpema E, Barabas K, Ballester Rosado CJ, Nguyen L, et al. (2008). Endocannabinoid signaling controls pyramidal cell specification and long-range axon patterning. Proc Natl Acad Sci U S A 105: 8760-8765. (Pubitemid 351987753)
79. Munro S, Thomas KL, Abushaar M, (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65. (Pubitemid 23305569)
80. Nakane S, Oka S, Arai S, Waku K, Ishima Y, Tokumura A, et al. (2002). 2-Arachidonoyl-sn-glycero-3-phosphate, an arachidonic acid-containing lysophosphatidic acid: occurrence and rapid enzymatic conversion to 2-arachidonoyl-sn-glycerol, a cannabinoid receptor ligand, in rat brain. Arch Biochem Biophys 402: 51-58. (Pubitemid 34848294)
81. Nomura DK, Morrison BE, Blankman JL, Long JZ, Kinsey SG, Marcondes MC, et al. (2011). Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation. Science 334: 809-813.
82. Oudin MJ, Hobbs C, Doherty P, (2011). DAGL-dependent endocannabinoid signalling: roles in axonal pathfinding, synaptic plasticity and adult neurogenesis. Eur J Neurosci 34: 1634-1646.
83. Pagotto U, Marsicano G, Cota D, Lutz B, Pasquali R, (2006). The emerging role of the endocannabinoid system in endocrine regulation and energy balance. Endocr Rev 27: 73-100. (Pubitemid 43228239)
84. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, Mechoulam R, et al. (2001). An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413: 527-531. (Pubitemid 32938751)
85. Richie-Jannetta R, Nirodi CS, Crews BC, Woodward DF, Wang JW, Duff PT, et al. (2010). Structural determinants for calcium mobilization by prostaglandin E2 and prostaglandin F2alpha glyceryl esters in RAW 264.7 cells and H1819 cells. Prostaglandins Other Lipid Mediat 92: 19-24.
86. Roloff AM, Anderson GR, Martemyanov KA, Thayer SA, (2010). Homer 1a gates the induction mechanism for endocannabinoid-mediated synaptic plasticity. J Neurosci 30: 3072-3081.
87. Sang N, Chen C, (2006). Lipid signaling and synaptic plasticity. Neuroscientist 12: 425-434. (Pubitemid 44316321)
88. Sang N, Zhang J, Chen C, (2006). PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons. J Physiol 572 (Pt 3): 735-745.
89. Sang N, Zhang J, Chen C, (2007). COX-2 oxidative metabolite of endocannabinoid 2-AG enhances excitatory glutamatergic synaptic transmission and induces neurotoxicity. J Neurochem 102: 1966-1977. (Pubitemid 47329266)
90. Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, et al. (2010). Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 13: 1113-1119.
91. Shonesy BC, Wang X, Rose KL, Ramikie TS, Cavener VS, Rentz T, et al. (2013). CaMKII regulates diacylglycerol lipase-alpha and striatal endocannabinoid signaling. Nat Neurosci 16: 456-463.
92. Sinor AD, Irvin SM, Greenberg DA, (2000). Endocannabinoids protect cerebral cortical neurons from in vitro ischemia in rats. Neurosci Lett 278: 157-160. (Pubitemid 30009481)
93. Stella N, Schweitzer P, Piomelli D, (1997). A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778. (Pubitemid 27375156)
94. Straiker A, Mackie K, (2005). Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones. J Physiol 569 (Pt 2): 501-517. (Pubitemid 41830118)
95. Straiker A, Mackie K, (2009). Cannabinoid signaling in inhibitory autaptic hippocampal neurons. Neuroscience 163: 190-201.
96. Straiker A, Gibson A, Mitjavila J, Blankman J, Hu S, Cravatt B, et al. (2013). ABHD12 deletion alters cannabinoid signaling and induces desensitization in autaptic hippocampal neurons. 23rd Annual Symposium on The Cannabinoids. International Cannabinoid Research Society: Research Triangle Park, NC, p. 46.
97. Straiker A, Hu SS, Long JZ, Arnold A, Wager-Miller J, Cravatt BF, et al. (2009). Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol Pharmacol 76: 1220-1227.
98. Straiker A, Wager-Miller J, Hu SS, Blankman JL, Cravatt BF, Mackie K, (2011). COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation. Br J Pharmacol 164: 1672-1683.
99. Sumislawski JJ, Ramikie TS, Patel S, (2011). Reversible gating of endocannabinoid plasticity in the amygdala by chronic stress: a potential role for monoacylglycerol lipase inhibition in the prevention of stress-induced behavioral adaptation. Neuropsychopharmacology 36: 2750-2761.
100. Szumlinski KK, Kalivas PW, Worley PF, (2006). Homer proteins: implications for neuropsychiatric disorders. Curr Opin Neurobiol 16: 251-257.
101. Takemiya T, Suzuki K, Sugiura H, Yasuda S, Yamagata K, Kawakami Y, et al. (2003). Inducible brain COX-2 facilitates the recurrence of hippocampal seizures in mouse rapid kindling. Prostaglandins Other Lipid Mediat 71: 205-216. (Pubitemid 36929791)
102. Tanimura A, Yamazaki M, Hashimotodani Y, Uchigashima M, Kawata S, Abe M, et al. (2010). The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase alpha mediates retrograde suppression of synaptic transmission. Neuron 65: 320-327.
103. Taschler U, Radner FP, Heier C, Schreiber R, Schweiger M, Schoiswohl G, et al. (2011). Monoglyceride lipase deficiency in mice impairs lipolysis and attenuates diet-induced insulin resistance. J Biol Chem 286: 17467-17477.
104. Thomas EA, Cravatt BF, Danielson PE, Gilula NB, Sutcliffe JG, (1997). Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J Neurosci Res 50: 1047-1052. (Pubitemid 28034660)
105. Waggoner DW, Johnson LB, Mann PC, Morris V, Guastella J, Bajjalieh SM, (2004). MuLK, a eukaryotic multi-substrate lipid kinase. J Biol Chem 279: 38228-38235. (Pubitemid 39295970)
106. Won YJ, Puhl HL, 3rd, Ikeda SR, (2009). Molecular reconstruction of mGluR5a-mediated endocannabinoid signaling cascade in single rat sympathetic neurons. J Neurosci 29: 13603-13612.
107. Wu CS, Zhu J, Wager-Miller J, Wang S, O'Leary D, Monory K, et al. (2010). Requirement of cannabinoid CB(1) receptors in cortical pyramidal neurons for appropriate development of corticothalamic and thalamocortical projections. Eur J Neurosci 32: 693-706.
108. Xie WL, Chipman JG, Robertson DL, Erikson RL, Simmons DL, (1991). Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci U S A 88: 2692-2696. (Pubitemid 21916484)
109. Yen CL, Stone SJ, Cases S, Zhou P, Farese RV, Jr, (2002). Identification of a gene encoding MGAT1, a monoacylglycerol acyltransferase. Proc Natl Acad Sci U S A 99: 8512-8517. (Pubitemid 34693593)
110. Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M, et al. (2006). Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci 26: 4740-4751. (Pubitemid 44315313)
111. Yoshida T, Uchigashima M, Yamasaki M, Katona I, Yamazaki M, Sakimura K, et al. (2011). Unique inhibitory synapse with particularly rich endocannabinoid signaling machinery on pyramidal neurons in basal amygdaloid nucleus. Proc Natl Acad Sci U S A 108: 3059-3064.
112. 2+ or by metabotropic glutamate receptors appear to arise from different pools of diacylglycerol lipase. PLoS ONE 6: e16305.
113. Zuardi AW, Hallak JE, Dursun SM, Morais SL, Sanches RF, Musty RE, et al. (2006). Cannabidiol monotherapy for treatment-resistant schizophrenia. J Psychopharmacol 20: 683-686. (Pubitemid 44321696)